Charles Schwab Investment Management Inc Sio Gene Therapies Inc. Transaction History

Charles Schwab Investment Management Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$0.55 - $1.47 $11,012 - $29,433	-20,023 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.07 - $2.89 $41,447 - $57,866	20,023 New	20,023 $55,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.